Faculty profile

Madeleine Sharp

ResearcherNeurology and NeurosurgeryMcGill University

This profile is built from public research funding records (CIHR, NSERC and SSHRC) and PubMed. We have not imported them from a McGill University directory, so their courses may be missing. Find their university profile.

Madeleine Sharp

Researcher

Neurology and Neurosurgery

Health Sciences

McGill University

Montreal, Quebec, Canada

Supervision signals

Has led research grants, which requires an independent research appointment. Ask their department whether they supervise graduate students.
11 publications in the last five years, latest in 2026.
Senior (last) author on 6 recent papers, a sign of leading a research group.
Principal investigator on 2 research grants (2 CIHR), most recently in 2025.

These signals come from public records, including CIHR, NSERC and SSHRC funding decisions. Ask the professor or the graduate program whether they are taking new students.

Academic metrics

Publications

Citations

h-index

Collaborators

Grants

Publications by year

Counts cover the works listed on the university profile; citation counts come from Dimensions.

Profiles and links

Search on Google Scholar

Find them onX · LinkedIn · Bluesky · YouTube

Signals and details

Research

Parkinson'S Disease Alzheimer'S Disease Biomarkers Cognition Cognitive Reserve Dementia Mri Vascular Dementia

Latest papers

Association Between Plasma Phosphorylated Tau-217 and Cognition in Parkinson's Disease.
Movement disorders : official journal of the Movement Disorder Society · 2026 · senior author
Weighing Open Science Against Research Participation Burden in Informed Consent: A Randomized Pilot Study.
Journal of empirical research on human research ethics : JERHRE · 2025
Selective Effects of Substantia Nigra and Locus Coeruleus Degeneration on Cognition in Parkinson's Disease.
Movement disorders : official journal of the Movement Disorder Society · 2025 · senior author

All 14 publications

Latest funding

Redefining Parkinson's disease dementia: an in-depth investigation into the causal role of common co-pathologies
CIHR · 2025 · Nominated PI
$1,269,900
Characterizing and predicting PD biological stages with neuroimaging across global populations
CIHR · 2024 · Co-investigator
$1,051,875
Development and validation of multi modal Parkinson's disease subtyping and progression biomarkers in multiple cohorts
CIHR · 2022 · Co-investigator
$875,925

All 4 grants and awards

14 publications.

Association Between Plasma Phosphorylated Tau-217 and Cognition in Parkinson's Disease.

Kouchache T, Chan T, Sun S, Liu L, Delva A, Gan-Or Z, Rosa-Neto P, Gagnon JF, Dagher A, Postuma RB, Sharp M

Movement disorders : official journal of the Movement Disorder Society2026Senior author

DOI: 10.1002/mds.70400 PMID: 42473272

Weighing Open Science Against Research Participation Burden in Informed Consent: A Randomized Pilot Study.

Iskander R, Kane P, Sharp M, Kimmelman J

Journal of empirical research on human research ethics : JERHRE2025

DOI: 10.1177/15562646251384573 PMID: 41069046

Selective Effects of Substantia Nigra and Locus Coeruleus Degeneration on Cognition in Parkinson's Disease.

Sun S, Madge V, Djordjevic J, Gagnon JF, Collins DL, Dagher A, Sharp M

Movement disorders : official journal of the Movement Disorder Society2025Senior author

DOI: 10.1002/mds.30148 PMID: 39945211

Predicting Parkinson's disease trajectory using clinical and functional MRI features: A reproduction and replication study.

Germani E, Bhagwat N, Dugré M, Gau R, Montillo AA, Nguyen KP, Sokolowski A, Sharp M, Poline JB, Glatard T

PloS one2025

DOI: 10.1371/journal.pone.0317566 PMID: 39982930

Online unsupervised performance-based cognitive testing: A feasible and reliable approach to scalable cognitive phenotyping of Parkinson's patients.

Balit N, Sun S, Zhang Y, Sharp M

Parkinsonism & related disorders2024Senior author

DOI: 10.1016/j.parkreldis.2024.107183 PMID: 39454300

Real-time auditory feedback for improving gait and walking in people with Parkinson's disease: a pilot and feasibility trial.

Mayo NE, Mate KKV, Fellows LK, Morais JA, Sharp M, Lafontaine AL, Hill ET, Dawes H, Sharkh AA

Pilot and feasibility studies2024

DOI: 10.1186/s40814-024-01542-z PMID: 39192343

Sleep spindle density and temporal clustering are associated with sleep-dependent memory consolidation in Parkinson's disease.

Lahlou S, Kaminska M, Doyon J, Carrier J, Sharp M

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine2024Senior author

DOI: 10.5664/jcsm.11080 PMID: 38427318

Longitudinal brain structure changes in Parkinson's disease: A replication study.

Sokołowski A, Bhagwat N, Chatelain Y, Dugré M, Hanganu A, Monchi O, McPherson B, Wang M, Poline JB, Sharp M, Glatard T

PloS one2024

DOI: 10.1371/journal.pone.0295069 PMID: 38295031

The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [18F]MK6240 Tau PET in Target Regions.

Tissot C, Servaes S, Lussier FZ, Ferrari-Souza JP, Therriault J, Ferreira PCL, Bezgin G, Bellaver B, Leffa DT, Mathotaarachchi SS, Chamoun M, Stevenson J, Rahmouni N, Kang MS, Pallen V, Margherita-Poltronetti N, Wang YT, Fernandez-Arias J, Benedet AL, Zimmer ER, Soucy JP, Tudorascu DL, Cohen AD, Sharp M, Gauthier S, Massarweh G, Lopresti B, Klunk WE, Baker SL, Villemagne VL, Rosa-Neto P, Pascoal TA

Journal of nuclear medicine : official publication, Society of Nuclear Medicine2023

DOI: 10.2967/jnumed.122.264434 PMID: 36396455

Dopaminergic medication increases motivation to exert cognitive control by reducing subjective effort costs in Parkinson's patients.

Bogdanov M, LoParco S, Otto AR, Sharp M

Neurobiology of learning and memory2022Senior author

DOI: 10.1016/j.nlm.2022.107652 PMID: 35724812

Something wrong or missing on this profile? Suggest a correction

Madeleine Sharp

Research

Latest papers

Latest funding

Association Between Plasma Phosphorylated Tau-217 and Cognition in Parkinson's Disease.

Weighing Open Science Against Research Participation Burden in Informed Consent: A Randomized Pilot Study.

Selective Effects of Substantia Nigra and Locus Coeruleus Degeneration on Cognition in Parkinson's Disease.

Predicting Parkinson's disease trajectory using clinical and functional MRI features: A reproduction and replication study.

Online unsupervised performance-based cognitive testing: A feasible and reliable approach to scalable cognitive phenotyping of Parkinson's patients.

Real-time auditory feedback for improving gait and walking in people with Parkinson's disease: a pilot and feasibility trial.

Sleep spindle density and temporal clustering are associated with sleep-dependent memory consolidation in Parkinson's disease.

Longitudinal brain structure changes in Parkinson's disease: A replication study.

The Association of Age-Related and Off-Target Retention with Longitudinal Quantification of [18F]MK6240 Tau PET in Target Regions.

Dopaminergic medication increases motivation to exert cognitive control by reducing subjective effort costs in Parkinson's patients.

Redefining Parkinson's disease dementia: an in-depth investigation into the causal role of common co-pathologies

Characterizing and predicting PD biological stages with neuroimaging across global populations

Development and validation of multi modal Parkinson's disease subtyping and progression biomarkers in multiple cohorts

Large-scale neurobiologically-informed phenotyping of cognition and behaviour in Parkinson's disease

Frequent collaborators

Jean-Baptiste Poline

Alain Dagher

Pedro Rosa-Neto

Jason Karamchandani

Jason Karamchandani

Julie Carrier

Jonathan Kimmelman

Martin Lévesque

Francesca Cicchetti

Marta Kaminska

Julien Doyon

Oury Monchi

Angela Genge

Martin Parent

Serge Gauthier

Jean-Paul Soucy

Julien Doyon

Thomas Durcan

Michel Panisset

Janelle Drouin-Ouellet

Serge Gauthier